Co-Expression of Molecular Chaperones to Enhance Soluble aPD-L1 scFv Production in Escherichia coli BL21(DE3)
Production of commercial antibodies commonly relies on mammalian expression platforms; however, these are associated with high production costs and technical challenges during large-scale cultivation. In this study, we aimed to develop an Escherichia coli-based platform for the production of an anti-PD-L1 single-chain...